PSMA enhances folate metabolism by hydrolyzingpolyglutamylated folates to monoglutamylated forms, increasing folateuptake and fueling DNA synthesis, repair, and epigenetic alterationsthat further drive prostate cancer growth. The gene discussed is FOLH1; the disease is prostate carcinoma.